Evidence map›Paper›PMID 33126725›Full record

ArticlePharmaceutics2020

Anti-Inflammatory Activity of a Cyclic Tetrapeptide in Mouse and Human Experimental Models.

Michał Zimecki, Jolanta Artym, Wojciech Kałas, Leon Strządała, Katarzyna Kaleta-Kuratewicz, Jan Kuryszko, Andrzej Kaszuba, Krzysztof Kaczmarek, Janusz Zabrocki

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Antiviral Activity of a Cyclic Pro-Pro-Molecules (Basel, Switzerland) · 2022
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Michał ZimeckiInstitute of Immunology and Experimental Therapy, Polish Academy of Sciences, ul. Weigla 12, 53-112 Wrocław, Poland.
Jolanta ArtymInstitute of Immunology and Experimental Therapy, Polish Academy of Sciences, ul. Weigla 12, 53-112 Wrocław, Poland.
Wojciech KałasInstitute of Immunology and Experimental Therapy, Polish Academy of Sciences, ul. Weigla 12, 53-112 Wrocław, Poland.
Leon StrządałaInstitute of Immunology and Experimental Therapy, Polish Academy of Sciences, ul. Weigla 12, 53-112 Wrocław, Poland.
Katarzyna Kaleta-KuratewiczDepartment of Biostructure and Animal Physiology, Wrocław University of Environmental and Life Sciences, ul. C. K. Norwida 25, 50-375 Wrocław, Poland.
Jan KuryszkoDepartment of Biostructure and Animal Physiology, Wrocław University of Environmental and Life Sciences, ul. C. K. Norwida 25, 50-375 Wrocław, Poland.
Andrzej KaszubaDepartment of Dermatology, Pediatric and Oncological Dermatology, Medical University of Łódź, Al. Kościuszki 4, 90-419 Łódź, Poland.
Krzysztof KaczmarekInstitute of Organic Chemistry, Łódź University of Technology, ul. Żeromskiego 116, 90-924 Łódź, Poland.
Janusz ZabrockiInstitute of Organic Chemistry, Łódź University of Technology, ul. Żeromskiego 116, 90-924 Łódź, Poland.
Polish Academy of Sciences · PLLodz University of Technology · PLWrocław University of Environmental and Life Sciences · PLMedical University of Lodz · PL

Funding

National Center of Science and Development PBS1/B7/10/2013Polish Agency of Industry Development POIG.01.04.00-10-028/09
6 · The paper itself

Abstract

A cyclic tetrapeptide Pro-Pro-Pheβ

Indexed as

colitiscyclic tetrapeptideoxazolonePGE2pimecrolimuspleurisyprostaglandin receptorstacrolimustoluene diisocyanate

Identifiers

PMID33126725
PMCPMC7693979
OpenAlexW3095630911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.